Novel Compound Heterozygous Variants in the FAS Gene Lead to Fetal Onset of Autoimmune Lymphoproliferative Syndrome (ALPS)
Journal of Clinical Immunology · 2025
DOI: 10.1007/s10875-024-01812-8 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Immunology, 2025. Verfasst von Qi Wu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Autoimmune Lymphoproliferative Syndrome, fas Receptor, Exome Sequencing, Heterozygote. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: "Sailing Program" of Shanghai Science and Technology Committee, Shanghai Municipal Technology Standards Project, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
OBJECTIVE: FAS gene defects lead to autoimmune lymphoproliferative syndrome (ALPS), which is often inherited in an autosomal dominant and rarely in an autosomal recessive manner. We report a case of a newborn girl with novel compound heterozygous variants in FAS and reveal the underlying mechanism. METHODS: Whole-exome sequencing (WES) was used to identify pathogenic variants. Multiparametric flow cytometry analysis, phosflow analysis, and FAS-induced apoptosis assays were used to explore the effects of the variants on FAS expression, apoptosis, and immunophenotype. The HEK293T cells were used to assess the impact of the variants on protein expression and FAS-induced apoptosis. RESULTS: The patient was born with hepatosplenomegaly, anemia, and thrombocytopenia. She also experienced COVID-19, rotavirus infection, herpes simplex virus infection, and severe pneumonia. The proportion of double-negative T cells (DNTs) was significantly elevated. Novel FAS compound heterozygous variants c.310T > A (p.C104S) and c.702_704del (p.T235del) were identified. The apoptotic ability of T cells was defective, and FAS expression on the surface of T cells was deficient. The T235del variant decreased FAS expression, and the C104S protein remained in the endoplasmic reticulum (ER) and could not translocate to the cell surface. Both mutations resulted in loss-of-function in terms of FAS-induced apoptosis in HEK293T cells. The DNTs were mainly terminally differentiated T (TEMRA) and CD45RA+HLA-DR+, with high expression of CD85j, PD-1, and CD57. The percentage of Th1, Tfh, and autoreactive B cells were significantly increased in the patient. The abnormal immunophenotyping was partially attenuated by sirolimus treatment. CONCLUSIONS: We identified two variants that significantly affect FAS expression or localization, leading to early disease onset of in the fetus. Abnormalities in the mTOR pathway are associated with a favorable response to sirolimus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, China.
- Department of Neonatology, Children's Hospital of Fudan University, Shanghai, China.
- Key Laboratory of Neonatal Diseases, Ministry of Health, Children's Hospital of Fudan University, Shanghai, China.
- Department of Respiratory Medicine, Children's Hospital of Fudan University, Shanghai, China.
- Clinical Genetic Center, Children's Hospital of Fudan University, Shanghai, China.
- Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, China. qinhua_zhou@fudan.edu.cn.
Förderung
- "Sailing Program" of Shanghai Science and Technology Committee
- Shanghai Municipal Technology Standards Project
- Shanghai Municipal Science and Technology Major Project
- “Sailing Program” of Shanghai Science and Technology Committee
Zitieren
APA
Wu, Q., Sun, B., Hou, J., Hui, X., Wang, C., Wang, W., Ying, W., Liu, L., Zhu, L., Wang, Y., Li, Q., Yu, M., Zhou, W., Chen, Y., Wu, B., Sun, J., Zhou, Q., Qian, F., & Wang, X. (2025). Novel Compound Heterozygous Variants in the FAS Gene Lead to Fetal Onset of Autoimmune Lymphoproliferative Syndrome (ALPS). Journal of Clinical Immunology. https://doi.org/10.1007/s10875-024-01812-8
Vancouver
Wu Q, Sun B, Hou J, Hui X, Wang C, Wang W, et al. Novel Compound Heterozygous Variants in the FAS Gene Lead to Fetal Onset of Autoimmune Lymphoproliferative Syndrome (ALPS). Journal of Clinical Immunology. 2025. doi:10.1007/s10875-024-01812-8
BibTeX
@article{Wu2025,
author = {Wu, Qi and Sun, Bijun and Hou, Jia and Hui, Xiaoying and Wang, Chenghao and Wang, Wenjie and Ying, Wenjing and Liu, Luyao and Zhu, Li and Wang, Ying and Li, Qifan and Yu, Meiping and Zhou, Weitao and Chen, Yao and Wu, Bingbing and Sun, Jinqiao and Zhou, Qinhua and Qian, Feng and Wang, Xiaochuan},
title = {Novel Compound Heterozygous Variants in the FAS Gene Lead to Fetal Onset of Autoimmune Lymphoproliferative Syndrome (ALPS)},
journal = {Journal of Clinical Immunology},
year = {2025},
doi = {10.1007/s10875-024-01812-8}
}
EUVIMED